Schwarz Dygos Wheeler Investment Advisors LLC Grows Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Schwarz Dygos Wheeler Investment Advisors LLC lifted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.9% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 4,109 shares of the company’s stock after purchasing an additional 228 shares during the period. Schwarz Dygos Wheeler Investment Advisors LLC’s holdings in GE HealthCare Technologies were worth $318,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Chicago Capital LLC boosted its stake in shares of GE HealthCare Technologies by 2.8% in the 3rd quarter. Chicago Capital LLC now owns 6,081 shares of the company’s stock worth $414,000 after buying an additional 163 shares during the last quarter. Chilton Capital Management LLC raised its holdings in GE HealthCare Technologies by 15.4% in the 4th quarter. Chilton Capital Management LLC now owns 1,227 shares of the company’s stock worth $95,000 after purchasing an additional 164 shares during the period. Procyon Advisors LLC raised its holdings in GE HealthCare Technologies by 5.2% in the 4th quarter. Procyon Advisors LLC now owns 3,555 shares of the company’s stock worth $275,000 after purchasing an additional 175 shares during the period. Meeder Advisory Services Inc. raised its holdings in GE HealthCare Technologies by 5.4% in the 4th quarter. Meeder Advisory Services Inc. now owns 3,634 shares of the company’s stock worth $281,000 after purchasing an additional 185 shares during the period. Finally, Forum Financial Management LP raised its holdings in GE HealthCare Technologies by 3.9% in the 3rd quarter. Forum Financial Management LP now owns 4,989 shares of the company’s stock worth $339,000 after purchasing an additional 186 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock traded up $0.29 during midday trading on Friday, reaching $86.24. 1,790,728 shares of the stock traded hands, compared to its average volume of 2,231,738. The company has a quick ratio of 0.83, a current ratio of 1.05 and a debt-to-equity ratio of 1.18. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.50. The stock’s fifty day moving average is $88.92 and its 200-day moving average is $78.45. The stock has a market cap of $39.35 billion, a P/E ratio of 28.56, a PEG ratio of 2.99 and a beta of 0.94.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The business had revenue of $5.20 billion for the quarter, compared to the consensus estimate of $5.09 billion. During the same quarter in the previous year, the company posted $1.31 EPS. The company’s revenue was up 5.3% compared to the same quarter last year. As a group, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be paid a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. The ex-dividend date of this dividend is Thursday, April 18th. GE HealthCare Technologies’s payout ratio is 3.97%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. HSBC assumed coverage on GE HealthCare Technologies in a report on Thursday, February 15th. They issued a “buy” rating and a $100.00 target price on the stock. Mizuho raised their target price on GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, April 11th. Morgan Stanley raised their price target on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a report on Monday, February 12th. Argus raised their price target on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a report on Monday, April 1st. Finally, Citigroup raised their price target on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $95.09.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.